Gilead Sciences (GILD) Declares $0.57 Quarterly Dividend; 3.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Gilead Sciences (GILD) PT Lowered to $87 at RBC Capital
October 26, 2018 7:24 AM EDTRBC Capital analyst Brian Abrahams lowered the price target on Gilead Sciences (NASDAQ: GILD) to $87.00 (from $89.00) while maintaining a Outperform rating.
... MoreGilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance
October 25, 2018 4:06 PM EDTGilead Sciences (NASDAQ: GILD) reported Q3 EPS of $1.84, $0.21 better than the analyst estimate of $1.63. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.38 billion.
GUIDANCE:
Gilead Sciences sees Q4 2018 revenue of $20.8-21.3 billion, versus the consensus of... More
